Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal Hyperplasia
- PMID: 30673011
- PMCID: PMC6317633
- DOI: 10.5935/abc.20180269
Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal Hyperplasia
Comment on
-
Rapamycin Combined with α-Cyanoacrylate Contributes to Inhibiting Intimal Hyperplasia in Rat Models.Arq Bras Cardiol. 2019 Jan;112(1):3-10. doi: 10.5935/abc.20180247. Epub 2018 Dec 17. Arq Bras Cardiol. 2019. PMID: 30570064 Free PMC article.
References
-
- Gooch KJ, Firstenberg MS, Shrefler BS, Scandling BW. Biomechanics and mechanobiology of saphenous vein grafts. J Biomech Eng. 2018;140(2) 020804-020804-16. - PubMed
-
- Mylonaki I, Allain E, Strano F, Alle'mann E, Corpataux J-M, Meda P, et al. Evaluating intimal hyperplasia under clinical conditions. Interact Cardiovasc Thorac Surg. 2018;27(3):427–436. - PubMed
-
- Chen HL, Liu K, Meng XY, Wen XD, You QS. Local application of rapamycin inhibits vein graft restenosis in rabbits. Transpl Proc. 2011;43(5):2017–2021. - PubMed
-
- Skalsky I, Szarszoi O, Filova E, Parizek M, Lytvynets A, Maluskova J, et al. A perivascular system releasing sirolimus prevented intimal hyperplasia in a rabbit model in a medium-term study. Int J Phamaceutics. 2012;427(2):311–319. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
